Carpal Tunnel SyndromePhase 4NCT03196817
Non-surgical Treatment of Carpal Tunnel Syndrome: Night Splint Versus Local Corticosteroid Infiltration
A Phase 4 study testing betamethasone dipropionate, betamethasone disodium phosphate and lidocaine 2% and Wrist splinting in people with Carpal Tunnel Syndrome, run by Hospital Alvorada at 1 site in Brazil.
Trial summary
Carpal tunnel syndrome (CTS) is the most common neuropathic compression syndrome of the upper limbs, caused by compression of the median nerve in the wrist. There is no gold standard for establishing the diagnosis of STC. The diagnosis can be based on clinical findings and electrodiagnostic tests. Read more about this study
- Who is it for?
- Ages 40 years and older
- Conditions the study is for
- Carpal Tunnel Syndrome
- What is being tested?
- betamethasone dipropionate, betamethasone disodium phosphate and lidocaine 2% and Wrist splinting
- Type of treatment
- Injection or infusion, Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 84 participants
- Where
- 1 siteBrazil
- Study dates
- 1 Aug 2016to Dec 2017
- Phase
- Phase 4
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adult patients aged 40 years or more,
- Have the diagnosis confirmed with electromyography (EMG),
- Four or more than six of the following clinical signs and symptoms suggested by Graham et al (CTS-6):
- Paraesthesia in the territory of the median nerve.
- Night hand paresthesia
- Atrophy of thenar muscles
Show all 18Show fewer
- Positive Tinel Sign
- Phalen Test Positive
- Loss of two point discrimination
- Sign a Research Ethics Committe, after reading and explanation of the proposed study.
- Non-inclusion criteria:
- Pretreatment with corticosteroids and splint
- Prior surgical treatment
- Traumatic or nontraumatic pathologies associated
- Hypersensitivity to corticosteroids
- CTS secondary to other pathology
- Refusal to sign a Research Ethics Committe.
- Fixed Paresthesia
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Non-surgical Treatment of Carpal Tunnel Syndrome: Night Splint Versus Local Corticosteroid Infiltration: Clinical Randomized Trial
Carpal tunnel syndrome (CTS) is the most common neuropathic compression syndrome of the upper limbs, caused by compression of the median nerve in the wrist. There is no gold standard for establishing the diagnosis of STC. The diagnosis can be based on clinical findings and electrodiagnostic tests. Treatment options can be divided into surgical and non-surgical procedures. Surgical interventions include open carpal tunnel release, mini incision or release of the endoscopic carpal tunnel. Nonsurgical include daily activities modification, oral anti-inflammatory drugs (NSAIDs), oral corticosteroids, splints, corticosteroid injections or other options (laser therapy, ultrasound or acupuncture)
The aim of this study is to compare randomly, conservative treatment for CTS with night splint of the wrist versus local infiltration of corticosteroids after a min-imum period of six months follow-up.
Patients will be divided into two groups: night orthesis group that will receive the prescription to purchase the orthesis and guide the use of it; and infiltration group of patients will be referred to the Moema Alvorada Hospital to carry out infiltration. These patients will be evaluated before application, one week, one month, three months and six months after intervention.
Read the detailed description
This study will be developed in the service of medical residency of surgery and microsurgery of the hand of Alvorada hospital (São Paulo - SP).
The Study Design is Randomized clinical trial according to the CONSORT STATEMENT (http://www.consort-statement.org) standards.
The number of participants will initially be 84 patients.
Inclusion criteria:
Adult patients 40 years of age or older with four or more of the following clinical signs and symptoms suggested by Graham et al. (CTS-6):
- Paresthesia in the territory of the median nerve.
- Nocturnal paresthesia of the hand
- Atrophy of the tenar musculature
- Positive Tinel Signal
- Positive Phalen Test
- Loss of discrimination of 2 points
All patients will be diagnosed with electromyography (EMG). All participants will sign an Research Ethics Committee of this institution, after reading and explaining the study proposal.
Criteria for non-inclusion:
Previous treatment with corticosteroids and felling in the last 6 months Previous surgical treatment Associated traumatic or non-traumatic pathologies Hypersensitivity to corticosteroids. CTS secondary to another pathology. Refusal to Research Ethics Committe. Fixed paresthesia
Randomization and Allocation:
The allocation of patients to the infiltration or nocturnal orthosis groups will be performed using opaque and numbered envelopes on their outer face with consecutive numbers. The draw of the method, for each envelope, will be done randomly and sequentially, using randomization software (available at: http://www.random.org), after the randomization, the envelopes will be sealed. The sealed envelope, containing the patient's allocation group, will be opened only at the doctor's office after verification of the criteria for inclusion and signing of the Research Ethics Committee signature. The randomization procedure was performed by a person not directly involved in the study.
Sampe Size:
Considering the difference of 30% in the improvement of nocturnal paresthesia, 95% confidence interval and statistical power of 80%, we calculated a sample of 84 patients. At 6 months
Interventions
The patients included in this study will be attended at the Santa Cruz IV Ambulatory of hand surgery outpatient clinic. Patients with a diagnosis of CTS will be referred for evaluation in this outpatient clinic.
After confirmation of the diagnosis of CTS with the presence of four or more of the six criteria proposed by Graham and confirmation by the EMG and application of the inclusion and non inclusion criteria in the study, eligible patients will be informed about the nature and purpose of the study, by reading the Research Ethics Committee of this institution; after signing will be registered. Only after signing the Research Ethics Committee and the patient's registration will the opaque and sealed envelope containing the patient's allocation be opened. Patients in the nocturnal orthoses group will receive prescriptions for the purchase of the orthosis and guidance on use at the same moment of randomization. Patients in the infiltration group will be referred to the Hospital Alvorada de Moema to perform the infiltration at the same moment of randomization.
Infiltration technique:
Patient seated, with elbow resting on the table, supine wrist, relaxed in dorsiflexion, after asepsis and antisepsis care a needle will be inserted located on the ulnar border of the radial flexor tendon of the carpus, with an angle of 30º directed to the carpal tunnel , with an association of betamethasone dipropionate, betamethasone disodium phosphate {diprospan®}, plus lidocaine (xylocaina®).
Night immobilization:
During the night time, the patient will wear a forearm-palmar splint, where the wrist will remain in the 15th degree of extension, until its removal in the morning. The nocturnal orthosis should be used by study period .
Outcomes
Primary Outcomes:
- Remission of nocturnal paresthesia after intervention - Evaluation to verify remission of nocturnal paresthesia, referred by the patient at the time of initial care.
- Boston Questionnaire (Levine):
A questionnaire developed for the purpose of evaluating the severity of symptoms and the degree of manual ability of patients with CTS. This is a self-reported questionnaire that assesses the severity of symptoms and the functional status of patients.
Secondary Outcome Measures:
- Visual Analogue Scale - EVA Pain Evaluation - The analogical visual scale of pain is formed by two bars, joined by a line with ten centimeters, that mark the beginning and the end. The start bar is "0" and indicates no pain. The end bar is the "10" and indicates the maximum pain. The patient was asked to register his pain with a stroke on that line joining the two bars. The gauging of the pain was performed by measuring the distance between the initial bar and the trait performed by the patient.
- Graham Criteria - CTS-6 Assessment of improvement of graham's cervix, which are signs and symptoms used for the diagnosis of CTS
- Conditions
- Carpal Tunnel Syndrome
- Being tested
- betamethasone dipropionate, betamethasone disodium phosphate and lidocaine 2%, Wrist splinting
- Keywords
- Random Allocation, Injections, Orthotic Devices
- Medical subject headings
- Carpal Tunnel Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
betamethasone dipropionate, betamethasone disodium phosphate and lidocaine 2%Drug
Also called Steroid injection
6.43 mg of betamethasone dipropionate, 2.63 mg of betamethasone disodium phosphate and 0.5 ml plus lidocaine 2%
Wrist splintingDevice
Also called wrist splints
Splinting only at night to maintain the wrist positioned in 15 degrees of extensionin.
| Study group | Role | What they receive |
|---|---|---|
| Carpal tunnel injection | Active comparator | Carpal tunnel injection (infiltration) group of patients will be referred to the Hospital Alvorada to carry out steroid injection. The injection in carpal tunnel will be an association of 6.43 mg of betamethasone dipropionate, 2.63 mg of betamethasone disodium phosphate and 0.5 ml plus lidocaine 2%, totaling 1.5 ml. Receives: Drug: betamethasone dipropionate, betamethasone disodium phosphate and lidocaine 2% |
| Wrist splinting | Active comparator | Wrist splinting will be use in the nigth time, remain the wrist in the 15th degree in extension, until its removal in the morning. Receives: Device: Wrist splinting |
What is being measured
The primary outcome is the main question the study is designed to answer.
Remission of symptoms
Remission of nocturnal paresthesia referred by the patient at six months the follow up.
Measured: 6 months
Boston Questionnaire (Levine)
A questionnaire developed for the purpose of evaluating the severity of symptoms and the degree of manual ability of patients with CTS.
Measured: 6 months
Secondary outcomes (2)
Visual Analogue Scale - EVA Pain Evaluation
The analogical visual scale of pain is formed by two bars, joined by a line with ten centimeters, that mark the beginning and the end. The start bar is "0" and indicates no pain. The end bar is the "10" and indicates the maximum pain.
Measured: 6 months
Graham Criteria - CTS-6
Assessment of improvement of graham's cervix, which are signs and symptoms used for the diagnosis of CTS
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jun 2017
- Study start1 Aug 2016
- Primary completion1 May 2017
- Study completionDec 2017 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (7)Papers the sponsor has linked to this study.
- Other trials for Carpal Tunnel SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 84 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hospital Alvorada
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, João Carlos Belloti, Hospital Alvorada
- Investigators
- Non-surgical T Infiltration, Principal investigator, Hospital Alvorada
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03196817
- Sponsor's protocol ID
- HAMJQ01
- Status last verified
- Jun 2017
- First submitted
- 21 Oct 2016
- Last updated
- 14 Aug 2017
- Results posted
- No
- Data monitoring committee
- Yes
- Individual data sharing
- Yes
Publications
Chen PC, Chuang CH, Tu YK, Bai CH, Chen CF, Liaw M. A Bayesian network meta-analysis: Comparing the clinical effectiveness of local corticosteroid injections using different treatment strategies for carpal tunnel syndrome. BMC Musculoskelet Disord. 2015 Nov 19;16:363. doi: 10.1186/s12891-015-0815-8.
PubMed 26585378Ly-Pen D, Andreu JL, Millan I, de Blas G, Sanchez-Olaso A. Comparison of surgical decompression and local steroid injection in the treatment of carpal tunnel syndrome: 2-year clinical results from a randomized trial. Rheumatology (Oxford). 2012 Aug;51(8):1447-54. doi: 10.1093/rheumatology/kes053. Epub 2012 Mar 30.
PubMed 22467087Meems M, Den Oudsten B, Meems BJ, Pop V. Effectiveness of mechanical traction as a non-surgical treatment for carpal tunnel syndrome compared to care as usual: study protocol for a randomized controlled trial. Trials. 2014 May 22;15:180. doi: 10.1186/1745-6215-15-180.
PubMed 24886455Graham B, Regehr G, Naglie G, Wright JG. Development and validation of diagnostic criteria for carpal tunnel syndrome. J Hand Surg Am. 2006 Jul-Aug;31(6):919-24.
PubMed 16886290Peters-Veluthamaningal C, Winters JC, Groenier KH, Meyboom-de Jong B. Randomised controlled trial of local corticosteroid injections for carpal tunnel syndrome in general practice. BMC Fam Pract. 2010 Jul 29;11:54. doi: 10.1186/1471-2296-11-54.
PubMed 20670438Ucan H, Yagci I, Yilmaz L, Yagmurlu F, Keskin D, Bodur H. Comparison of splinting, splinting plus local steroid injection and open carpal tunnel release outcomes in idiopathic carpal tunnel syndrome. Rheumatol Int. 2006 Nov;27(1):45-51. doi: 10.1007/s00296-006-0163-y. Epub 2006 Jul 27.
PubMed 16871409Carlson H, Colbert A, Frydl J, Arnall E, Elliot M, Carlson N. Current options for nonsurgical management of carpal tunnel syndrome. Int J Clin Rheumtol. 2010 Feb;5(1):129-142. doi: 10.2217/IJR.09.63.
PubMed 20490348
Study at a glance
From the registry record, last updated by the sponsor on 14 Aug 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Non-surgical Treatment of Carpal Tunnel Syndrome: Night Splint Versus Local Corticosteroid Infiltration: Clinical Randomized Trial
- ClinicalTrials.gov ID
- NCT03196817
- Acronym / sponsor ID
- HAMJQ01
- Conditions
- Carpal Tunnel Syndrome
- Keywords
- Random Allocation, Injections, Orthotic Devices
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 84 participants (actual)
- Lead sponsor
- Hospital AlvoradaUniversity, hospital or other
- Study start
- 1 Aug 2016 (actual)
- Primary completion
- 1 May 2017 (actual)
- Study completion
- Dec 2017 (estimated)
- First posted
- 23 Jun 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Carpal tunnel syndrome (CTS) is the most common neuropathic compression syndrome of the upper limbs, caused by compression of the median nerve in the wrist. There is no gold standard for establishing the diagnosis of STC. The diagnosis can be based on clinical findings and electrodiagnostic tests. Treatment options can be divided into surgical and non-surgical procedures. Surgical interventions include open carpal tunnel release, mini incision or release of the endoscopic carpal tunnel. Nonsurgical include daily activities modification, oral anti-inflammatory drugs (NSAIDs), oral corticosteroids, splints, corticosteroid injections or other options (laser therapy, ultrasound or acupuncture)
The aim of this study is to compare randomly, conservative treatment for CTS with night splint of the wrist versus local infiltration of corticosteroids after a min-imum period of six months follow-up.
Patients will be divided into two groups: night orthesis group that will receive the prescription to purchase the orthesis and guide the use of it; and infiltration group of patients will be referred to the Moema Alvorada Hospital to carry out infiltration. These patients will be evaluated before application, one week, one month, three months and six months after intervention.
Detailed description
This study will be developed in the service of medical residency of surgery and microsurgery of the hand of Alvorada hospital (São Paulo - SP).
The Study Design is Randomized clinical trial according to the CONSORT STATEMENT (http://www.consort-statement.org) standards.
The number of participants will initially be 84 patients.
Inclusion criteria:
Adult patients 40 years of age or older with four or more of the following clinical signs and symptoms suggested by Graham et al. (CTS-6):
- Paresthesia in the territory of the median nerve.
- Nocturnal paresthesia of the hand
- Atrophy of the tenar musculature
- Positive Tinel Signal
- Positive Phalen Test
- Loss of discrimination of 2 points
All patients will be diagnosed with electromyography (EMG). All participants will sign an Research Ethics Committee of this institution, after reading and explaining the study proposal.
Criteria for non-inclusion:
Previous treatment with corticosteroids and felling in the last 6 months Previous surgical treatment Associated traumatic or non-traumatic pathologies Hypersensitivity to corticosteroids. CTS secondary to another pathology. Refusal to Research Ethics Committe. Fixed paresthesia
Randomization and Allocation:
The allocation of patients to the infiltration or nocturnal orthosis groups will be performed using opaque and numbered envelopes on their outer face with consecutive numbers. The draw of the method, for each envelope, will be done randomly and sequentially, using randomization software (available at: http://www.random.org), after the randomization, the envelopes will be sealed. The sealed envelope, containing the patient's allocation group, will be opened only at the doctor's office after verification of the criteria for inclusion and signing of the Research Ethics Committee signature. The randomization procedure was performed by a person not directly involved in the study.
Sampe Size:
Considering the difference of 30% in the improvement of nocturnal paresthesia, 95% confidence interval and statistical power of 80%, we calculated a sample of 84 patients. At 6 months
Interventions
The patients included in this study will be attended at the Santa Cruz IV Ambulatory of hand surgery outpatient clinic. Patients with a diagnosis of CTS will be referred for evaluation in this outpatient clinic.
After confirmation of the diagnosis of CTS with the presence of four or more of the six criteria proposed by Graham and confirmation by the EMG and application of the inclusion and non inclusion criteria in the study, eligible patients will be informed about the nature and purpose of the study, by reading the Research Ethics Committee of this institution; after signing will be registered. Only after signing the Research Ethics Committee and the patient's registration will the opaque and sealed envelope containing the patient's allocation be opened. Patients in the nocturnal orthoses group will receive prescriptions for the purchase of the orthosis and guidance on use at the same moment of randomization. Patients in the infiltration group will be referred to the Hospital Alvorada de Moema to perform the infiltration at the same moment of randomization.
Infiltration technique:
Patient seated, with elbow resting on the table, supine wrist, relaxed in dorsiflexion, after asepsis and antisepsis care a needle will be inserted located on the ulnar border of the radial flexor tendon of the carpus, with an angle of 30º directed to the carpal tunnel , with an association of betamethasone dipropionate, betamethasone disodium phosphate {diprospan®}, plus lidocaine (xylocaina®).
Night immobilization:
During the night time, the patient will wear a forearm-palmar splint, where the wrist will remain in the 15th degree of extension, until its removal in the morning. The nocturnal orthosis should be used by study period .
Outcomes
Primary Outcomes:
- Remission of nocturnal paresthesia after intervention - Evaluation to verify remission of nocturnal paresthesia, referred by the patient at the time of initial care.
- Boston Questionnaire (Levine):
A questionnaire developed for the purpose of evaluating the severity of symptoms and the degree of manual ability of patients with CTS. This is a self-reported questionnaire that assesses the severity of symptoms and the functional status of patients.
Secondary Outcome Measures:
- Visual Analogue Scale - EVA Pain Evaluation - The analogical visual scale of pain is formed by two bars, joined by a line with ten centimeters, that mark the beginning and the end. The start bar is "0" and indicates no pain. The end bar is the "10" and indicates the maximum pain. The patient was asked to register his pain with a stroke on that line joining the two bars. The gauging of the pain was performed by measuring the distance between the initial bar and the trait performed by the patient.
- Graham Criteria - CTS-6 Assessment of improvement of graham's cervix, which are signs and symptoms used for the diagnosis of CTS
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Carpal tunnel injection | Active comparator | Drug: betamethasone dipropionate, betamethasone disodium phosphate and lidocaine 2%Carpal tunnel injection (infiltration) group of patients will be referred to the Hospital Alvorada to carry out steroid injection. The injection in carpal tunnel will be an association of 6.43 mg of betamethasone dipropionate, 2.63 mg of betamethasone disodium phosphate and 0.5 ml plus lidocaine 2%, totaling 1.5 ml. |
| Wrist splinting | Active comparator | Device: Wrist splintingWrist splinting will be use in the nigth time, remain the wrist in the 15th degree in extension, until its removal in the morning. |
Who may qualify
- Ages
- 40 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (18 listed)
- Adult patients aged 40 years or more,
- Have the diagnosis confirmed with electromyography (EMG),
- Four or more than six of the following clinical signs and symptoms suggested by Graham et al (CTS-6):
- Sign a Research Ethics Committe, after reading and explanation of the proposed study.
- Pretreatment with corticosteroids and splint
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| betamethasone dipropionate, betamethasone disodium phosphate and lidocaine 2%Also: Steroid injection6.43 mg of betamethasone dipropionate, 2.63 mg of betamethasone disodium phosphate and 0.5 ml plus lidocaine 2% | Drug | Carpal tunnel injection |
| Wrist splintingAlso: wrist splintsSplinting only at night to maintain the wrist positioned in 15 degrees of extensionin. | Device | Wrist splinting |
Primary outcome
Remission of symptoms
Time frame: 6 months
Remission of nocturnal paresthesia referred by the patient at six months the follow up.
Boston Questionnaire (Levine)
Time frame: 6 months
A questionnaire developed for the purpose of evaluating the severity of symptoms and the degree of manual ability of patients with CTS.
2 secondary outcomes
Visual Analogue Scale - EVA Pain Evaluation
Time frame: 6 months
Graham Criteria - CTS-6
Time frame: 6 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Aug 2017.
- Background: PubMed 26585378Chen PC, Chuang CH, Tu YK, Bai CH, Chen CF, Liaw M. A Bayesian network meta-analysis: Comparing the clinical effectiveness of local corticosteroid injections using different treatment strategies for carpal tunnel syndrome. BMC Musculoskelet Disord. 2015 Nov 19;16:363. doi: 10.1186/s12891-015-0815-8.
- Background: PubMed 22467087Ly-Pen D, Andreu JL, Millan I, de Blas G, Sanchez-Olaso A. Comparison of surgical decompression and local steroid injection in the treatment of carpal tunnel syndrome: 2-year clinical results from a randomized trial. Rheumatology (Oxford). 2012 Aug;51(8):1447-54. doi: 10.1093/rheumatology/kes053. Epub 2012 Mar 30.
- Background: PubMed 24886455Meems M, Den Oudsten B, Meems BJ, Pop V. Effectiveness of mechanical traction as a non-surgical treatment for carpal tunnel syndrome compared to care as usual: study protocol for a randomized controlled trial. Trials. 2014 May 22;15:180. doi: 10.1186/1745-6215-15-180.
- Background: PubMed 16886290Graham B, Regehr G, Naglie G, Wright JG. Development and validation of diagnostic criteria for carpal tunnel syndrome. J Hand Surg Am. 2006 Jul-Aug;31(6):919-24.
- Background: PubMed 20670438Peters-Veluthamaningal C, Winters JC, Groenier KH, Meyboom-de Jong B. Randomised controlled trial of local corticosteroid injections for carpal tunnel syndrome in general practice. BMC Fam Pract. 2010 Jul 29;11:54. doi: 10.1186/1471-2296-11-54.
- Background: PubMed 16871409Ucan H, Yagci I, Yilmaz L, Yagmurlu F, Keskin D, Bodur H. Comparison of splinting, splinting plus local steroid injection and open carpal tunnel release outcomes in idiopathic carpal tunnel syndrome. Rheumatol Int. 2006 Nov;27(1):45-51. doi: 10.1007/s00296-006-0163-y. Epub 2006 Jul 27.
- Background: PubMed 20490348Carlson H, Colbert A, Frydl J, Arnall E, Elliot M, Carlson N. Current options for nonsurgical management of carpal tunnel syndrome. Int J Clin Rheumtol. 2010 Feb;5(1):129-142. doi: 10.2217/IJR.09.63.
- Individual participant dataSharing planned: Yes
Related trials for Carpal Tunnel Syndrome
Not yet recruitingObservational study
Postural Control and Balance Performance in Patients With Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS), Postural Assessment
Recruiting
Comparison of Wrist Splint Positions in Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS), Peripheral Neuropathies
Recruiting
Effects of Repetitive Peripheral Magnetic Stimulation(rPMS) on CTS(Carpal Tunnel Syndrome)
Carpal Tunnel Syndrome (CTS)
Recruiting
Hand Function Outcome After the Application of Transfer Energy Capacitive and Resistive on Post-burn Patients Presented With Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS) Post-burn
Not yet recruiting
Effect of Progressive Gamified Motor Rehabilitation After Carpal Tunnel Release
Carpal Tunnel Surgery
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Non-surgical T Infiltration principal investigator
Hospital Alvorada
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing betamethasone dipropionate, betamethasone disodium phosphate and lidocaine 2% and Wrist splinting in people with Carpal Tunnel Syndrome, run by Hospital Alvorada at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 18 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 14 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Remission of symptoms (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03196817, which also lists 7 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2017.